Exact Mass: 607.3118166

Exact Mass Matches: 607.3118166

Found 46 metabolites which its exact mass value is equals to given mass value 607.3118166, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Chymostatin

2-[[1-(2-Amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[4-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors

   

Chymostatin

2-({[(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)({3-methyl-1-[(1-oxo-3-phenylpropan-2-yl)carbamoyl]butyl}carbamoyl)methyl]carbamoyl}amino)-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

PC(2:0/5-iso PGF2VI)

(2-{[(2R)-3-(acetyloxy)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}propyl phosphono]oxy}ethyl)trimethylazanium

C28H50NO11P (607.312132)


PC(2:0/5-iso PGF2VI) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/5-iso PGF2VI), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

PC(5-iso PGF2VI/2:0)

(2-{[(2R)-2-(acetyloxy)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}propyl phosphono]oxy}ethyl)trimethylazanium

C28H50NO11P (607.312132)


PC(5-iso PGF2VI/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(5-iso PGF2VI/2:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

Chymostatin A|Chymostatin C

Chymostatin A|Chymostatin C

C31H41N7O6 (607.3118166)


   
   
   

Phe Lys Gln Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Phe Lys Trp Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C31H41N7O6 (607.3118166)


   

Phe Gln Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Phe Gln Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Phe Trp Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-4-carbamoylbutanoic acid

C31H41N7O6 (607.3118166)


   

Phe Trp Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Lys Phe Gln Trp

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]butanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Lys Phe Trp Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]butanoic acid

C31H41N7O6 (607.3118166)


   

Lys Gln Phe Trp

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Lys Gln Trp Phe

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

Lys Trp Phe Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]butanoic acid

C31H41N7O6 (607.3118166)


   

Lys Trp Gln Phe

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]butanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

Gln Phe Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Gln Phe Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Gln Lys Phe Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N7O6 (607.3118166)


   

Gln Lys Trp Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

Gln Trp Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Gln Trp Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

Trp Phe Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]hexanamido]-4-carbamoylbutanoic acid

C31H41N7O6 (607.3118166)


   

Trp Phe Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-carbamoylbutanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Trp Lys Phe Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C31H41N7O6 (607.3118166)


   

Trp Lys Gln Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-4-carbamoylbutanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

Trp Gln Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-phenylpropanamido]hexanoic acid

C31H41N7O6 (607.3118166)


   

Trp Gln Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]hexanamido]-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)


   

PKHdiA-PE

1-hexadecanoyl-2-(4-oxo-6-carboxy-5E-hexenoyl)-sn-glycero-3-phosphoethanolamine

C28H50NO11P (607.312132)


   

OOB-PS

1-(9Z-octadecenoyl)-2-(4-oxobutryl)-sn-glycero-3-phosphoserine

C28H50NO11P (607.312132)


   
   
   

(2R)-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate

(2R)-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate

C28H50NO11P (607.312132)


   

2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3- phosphocholine

2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3- phosphocholine

C28H50NO11P (607.312132)


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl.

   
   
   
   
   
   
   
   
   

(2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

(2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

C31H41N7O6 (607.3118166)